Back to Search
Start Over
Resting-State Network Alterations Differ between Alzheimer’s Disease Atrophy Subtypes
- Source :
- Cerebral Cortex, Cereb Cortex, Cerebral cortex 31(11), 4901-4915 (2021). doi:10.1093/cercor/bhab130
- Publication Year :
- 2021
- Publisher :
- Oxford University Press (OUP), 2021.
-
Abstract
- Several Alzheimer’s disease (AD) atrophy subtypes were identified, but their brain network properties are unclear. We analyzed data from two independent datasets, including 166 participants (103 AD/63 controls) from the DZNE-longitudinal cognitive impairment and dementia study and 151 participants (121 AD/30 controls) from the AD neuroimaging initiative cohorts, aiming to identify differences between AD atrophy subtypes in resting-state functional magnetic resonance imaging intra-network connectivity (INC) and global and nodal network properties. Using a data-driven clustering approach, we identified four AD atrophy subtypes with differences in functional connectivity, accompanied by clinical and biomarker alterations, including a medio-temporal-predominant (S-MT), a limbic-predominant (S-L), a diffuse (S-D), and a mild-atrophy (S-MA) subtype. S-MT and S-D showed INC reduction in the default mode, dorsal attention, visual and limbic network, and a pronounced reduction of “global efficiency” and decrease of the “clustering coefficient” in parietal and temporal lobes. Despite severe atrophy in limbic areas, the S-L exhibited only marginal global network but substantial nodal network failure. S-MA, in contrast, showed limited impairment in clinical and cognitive scores but pronounced global network failure. Our results contribute toward a better understanding of heterogeneity in AD with the detection of distinct differences in functional connectivity networks accompanied by CSF biomarker and cognitive differences in AD subtypes.
- Subjects :
- pathology [Cognitive Dysfunction]
graph theory
Cognitive Neuroscience
pathology [Alzheimer Disease]
resting-state connectivity
03 medical and health sciences
Cellular and Molecular Neuroscience
methods [Magnetic Resonance Imaging]
0302 clinical medicine
Atrophy
Neuroimaging
Alzheimer Disease
medicine
Humans
Dementia
Cognitive Dysfunction
ddc:610
Default mode network
030304 developmental biology
pathology [Atrophy]
0303 health sciences
medicine.diagnostic_test
Resting state fMRI
business.industry
brain structure
Brain
Cognition
medicine.disease
Magnetic Resonance Imaging
independent component analysis
Biomarker (medicine)
Original Article
Functional magnetic resonance imaging
business
Alzheimer’s disease
Neuroscience
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 14602199 and 10473211
- Volume :
- 31
- Database :
- OpenAIRE
- Journal :
- Cerebral Cortex
- Accession number :
- edsair.doi.dedup.....f2f99c2b6fb1c42fbda58ca3893bfa07
- Full Text :
- https://doi.org/10.1093/cercor/bhab130